Domenico M. Taglieri, Ph.D. - Publications

Affiliations: 
2011 Physiology and Biophysics University of Illinois at Chicago, Chicago, IL, United States 
Area:
Biochemistry, Molecular Biology

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Carley AN, Taglieri DM, Bi J, Solaro RJ, Lewandowski ED. Metabolic efficiency promotes protection from pressure overload in hearts expressing slow skeletal troponin I. Circulation. Heart Failure. 8: 119-27. PMID 25424393 DOI: 10.1161/Circheartfailure.114.001496  0.512
2014 Taglieri DM, Ushio-Fukai M, Monasky MM. P21-activated kinase in inflammatory and cardiovascular disease. Cellular Signalling. 26: 2060-9. PMID 24794532 DOI: 10.1016/J.Cellsig.2014.04.020  0.318
2014 Taglieri DM, Johnson KR, Burmeister BT, Monasky MM, Spindler MJ, DeSantiago J, Banach K, Conklin BR, Carnegie GK. The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy. Journal of Molecular and Cellular Cardiology. 66: 27-40. PMID 24161911 DOI: 10.1016/J.Yjmcc.2013.10.010  0.551
2013 Monasky MM, Taglieri DM, Henze M, Warren CM, Utter MS, Soergel DG, Violin JD, Solaro RJ. The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium. American Journal of Physiology. Heart and Circulatory Physiology. 305: H856-66. PMID 23873795 DOI: 10.1152/Ajpheart.00327.2013  0.53
2013 Jeong EM, Monasky MM, Gu L, Taglieri DM, Patel BG, Liu H, Wang Q, Greener I, Dudley SC, Solaro RJ. Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties. Journal of Molecular and Cellular Cardiology. 56: 44-54. PMID 23247392 DOI: 10.1016/J.Yjmcc.2012.12.003  0.581
2013 Monasky MM, Taglieri DM, Jacobson AK, Haizlip KM, Solaro RJ, Janssen PM. Post-translational modifications of myofilament proteins involved in length-dependent prolongation of relaxation in rabbit right ventricular myocardium. Archives of Biochemistry and Biophysics. 535: 22-9. PMID 23085150 DOI: 10.1016/J.Abb.2012.10.005  0.54
2012 Burmeister BT, Taglieri DM, Wang L, Carnegie GK. Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heart. The Journal of Biological Chemistry. 287: 40535-46. PMID 23045525 DOI: 10.1074/Jbc.M112.385641  0.549
2012 Lovelock JD, Monasky MM, Jeong EM, Lardin HA, Liu H, Patel BG, Taglieri DM, Gu L, Kumar P, Pokhrel N, Zeng D, Belardinelli L, Sorescu D, Solaro RJ, Dudley SC. Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity. Circulation Research. 110: 841-50. PMID 22343711 DOI: 10.1161/Circresaha.111.258251  0.534
2012 Monasky MM, Taglieri DM, Patel BG, Chernoff J, Wolska BM, Ke Y, Solaro RJ. p21-activated kinase improves cardiac contractility during ischemia-reperfusion concomitant with changes in troponin-T and myosin light chain 2 phosphorylation. American Journal of Physiology. Heart and Circulatory Physiology. 302: H224-30. PMID 22037191 DOI: 10.1152/Ajpheart.00612.2011  0.596
2012 Jeong E, Monasky MM, Gu L, Taglieri DM, Patel BG, Wang Q, Lardin H, Greener I, Solaro RJ, Dudley SC. Tetrahydrobiopterin Improves Diastolic Heart Failure by Increasing Myofilament Calcium Sensitivity Journal of Cardiac Failure. 18. DOI: 10.1016/J.Cardfail.2012.06.022  0.505
2012 Ke Y, Taglieri DM, Monasky MM, Solaro RJ. Erratum: Inhibition of angiotensin II-induced ventricular hypertrophy and fibrosis by modulation of Pak1 activity (Biophysical Journal (2012) (556a)) Biophysical Journal. 102. DOI: 10.1016/J.Bpj.2012.02.044  0.519
2012 Ke Y, Taglieri DM, Michelle MM, Solaro RJ. Inhibition of Angiotensin II-Induced Ventricular Hypertrophy and Fibrosis by Modulation of Pak1 Activity Biophysical Journal. 102. DOI: 10.1016/J.Bpj.2011.11.3032  0.593
2011 Liu W, Zi M, Naumann R, Ulm S, Jin J, Taglieri DM, Prehar S, Gui J, Tsui H, Xiao RP, Neyses L, Solaro RJ, Ke Y, Cartwright EJ, Lei M, et al. Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart. Circulation. 124: 2702-15. PMID 22082674 DOI: 10.1161/Circulationaha.111.048785  0.592
2011 Taglieri DM, Monasky MM, Knezevic I, Sheehan KA, Lei M, Wang X, Chernoff J, Wolska BM, Ke Y, Solaro RJ. Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A. Journal of Molecular and Cellular Cardiology. 51: 988-96. PMID 21971074 DOI: 10.1016/J.Yjmcc.2011.09.016  0.607
2011 Taglieri DM, Knezevic II, Chernoff J, Solaro RJ, Ke Y. Erk1-Mediated Development of Left Ventricular Cardiac Hypertrophy in a P21 Activated Kinase-1 (Pak1) Knockout Mouse Model Biophysical Journal. 100: 289a. DOI: 10.1016/J.Bpj.2010.12.1783  0.562
Show low-probability matches.